CR2 Revision 2 Flashcards

1
Q

What underlying pathologies might cause angina if the problem is occuring from a reduced o2 supply? [2]

A

Reduced O2 demand:

  1. CAD:
    - Atherosclerosis
    - Post radiation therapy
    - Spasm: normal coronary arteries which spasm causing temporary occlusion
  2. Anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What underlying pathologies might cause angina if the problem is occuring from an increased myocardial demand? [3]

A
  1. Left ventricular hypertrophy (from: HTN, aortic stenosis, aortic regurgiation, hypertrophic cardiomyopathy)
  2. Right ventricular hypertophy (from: pulmonary HTN, pulmnonary stenosis)
  3. Rapid tachycardiarythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the pathway you would undertake to diagnose stable angina

A

Clinical assesment:
How many of the following do they have?
- General chest discomfort lasting 5/10 mins?
- Is this provoked by exercise?
- Is this relieved by rest or nitrates?

  1. Answer = <1, No diagnostic testing, no medication
  2. Answer = 2 characteristics = atypical angina
  3. Answer = 3 characteristics = typical angina

If Atypical angina or typical angina: initial management and investigations:
- CTCA
- Functional imaging if CTCA inconclusive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What key factors about chest pain would you ask someone with angina? [5]

A

Character
Location
Radiation
Duration
Provocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the managment pathway for someone with angina

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do different drugs / therapies target different physiological areas to relieve angina symptoms?

A

Increasing O2 delivery
Increase coronary blood flow:
- Nitrates
- CCBs
- Revasc.
- Nicorandil (Combination of K+ blocker and nitrate)

Reducing myocardial demand:

1. Reduce HR:
- BB
- ivabradine (funny current (If) inhibitor)

2. Decrease LV wall tension:
- BB
- Nitrates
- Nicorandil
- CCBs
- Ranolazine (Na+ pump inhibitor)

3. Reduce contractility:
- BB
- CCBs

4. Modify energy metabolism
- Trimetazidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can you pharmacologically reduce risk of MI for patients who are at risk of angina? [4]

A
  1. Aspirin: this produces an antithrombotic effect that helps to reduce the risk of heart attacks and strokes.
  2. Statins: reduces cholesterol (HMG Reductase inhibitor)
  3. Ace Inhibitor: If there is hypertension or diabetes or other comorbidities
  4. P2Y12 receptor
    antagonist
    : After PCI or if allergic to statins (P2Y12 receptor blockers are another group of antiplatelet drugs. This group of drugs includes: clopidogrel, ticlopidine, ticagrelor, prasugrel, and cangrelor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drug is initially used to treat stable angina? [1]

A

glyceryl trinitrate (GTN).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 3 risk factors for thromboembolism - what is the name for these factors combined? [4]

A

Virchow’s Triad

Endothelial injury

Stasis or turbulence of blood flow

Blood hypercoagulability

Inflammation: causes procaogulant state - acts in combination with one of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does blood stasis increase risk of clot? [2]

What are 4 risk factors that cause reduced blood flow / blood stasis? [4]

A

Why does blood stasis increase risk of clot? [2]
- less release of NO and prostacyclin from endothelium when blood is static

What are 4 risk factors that cause reduced blood flow / blood stasis? [4]
Immobilisation in bed following surgery or other conditions eg hip/pelvis fracture

Long-haul flights especially >8hours (prolonged sitting )

Obesity causing reduced exercise and decrease in venous return in deep leg veins

Sickle cell disease: red cell precipitation can occlude vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why does vein wall pathology increase chance of DVT / PE?

How can vein wall pathology / damage occur? [3]

A

Heparan sulfate projects out of the endothelial wall. These projections prevent platelet adhesion to intact endothelial membrane. If damaged - less heparan sulfate:
- increases risk of clot formation, especially if combined with reduced blood flow

Vein wall pathology can occur from:
a) smoking / alchohol
b) diabetes
c) chronic inflam disease (RA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you diagnose DVT?

A

Use Wells’ Score:

  1. Add up points on the score: 2 points or more is likely. 1 is unlikely
  2. If 2 or more score: have proximal leg vein ultrasound
    i) have positive scan - give treatment
    iI) have negative scan, repeat in 6-8 days - do a D Dimer test
    a) if D-dimer is positive: repeat scan in 6-8 days
    b) if second sacan D-dimer is negative - consider alternative disease, but discuss symptoms with patient so they can look out for it
  3. Venography - gold standard

* o D-dimer is fibrin degradation product
o Is a marker of fibrin formation
o Raised in VTE and other pathologies
D dimer: fibrin degradation product released when thrombus is degraded by by fibrinolysis low D dimer = low DVT risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why might someone have hypercoaguable blood? [3]

When would you consider hypercoagulable states for DVT?

A

Why might someone have hypercoaguable blood?
- Antithrombin deficiency
- Protein C or S defiency (anti-coagulant proteins)
- Factor V Leiden mutation :causes resistance to activated protein C

Consider when no obvious signs for VTE/ PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name 4 risk factors for thromboembolism

A

Pregnancy: enlarged fetus compresses veins (increases venous stasis), increased production of clotting factors to stop bleeding during birth

Prolonged immobilisation

Previous VTE Event:: Previous valve damage; Underlying cause for previous VTE and not may be left untreated treated underlying cause then may cause again

Contraceptive pill & HRT

Long haul travel

Cancer: can damage endothelium wall; increased risk from clotting factors

Heart failure : poor circulation of vascular system; more likely to be immobile

Obesity

Surgery: causing endothelial damage; causing immoblisation; causes increase in clotting factors

Severge burns endothlial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How would you investigate for PE?

Classification system? [1]
ECG? [3]
CXR? [1]
ABG [1]

A

o Wells Score greater than 4

ECG - sinus tachycardia, right heart strain. T-wave inversion on anterior leads (V1-V3). Classic finding: S (deep S wave in lead I), Q ( present in lead III) and T (inverted T in lead III).

o CXR- possible small pleural effusion, peripheral wedge shaped density above diaphragm, focal oligemia. Most common finding with PE patients is a normal CXR, but used to excludes other diagnoses

o ABG - often hypoxic, low CO2 (due to hyperventilation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What Wells score would indicate PE? [1]

A

greater than 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What type of imaging would be best for diagnosis of PE?

A

CT pulmonary angiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain how PE can cause cardiac failure xx

A
  • Right ventricle has thin muscle (pulmonary vasculature is a low pressure system)
    - Increased pressure in the pulmonary vasculature due to PE
    - Thin right ventricle has to work harder / dilates and is understrain
    - Dilatation of right ventricle gets in the way of the left ventricle (pushes through interventricular septum) – less filling of the LV: fall in BP / decreased CO
    - This causes release of adrenaline / noradrenaline: causes PE to vasoconstrict.
    - Repeats cycle – can lead to MI / arrthymia
    - So main cause of death is right sided heart failure leading to left sided heart failure  cardiac arrest
    - ALSO get patent foramen ovale in 1/3 patients: severe hypoxaemia & increased risk of stroke
    -
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Name & briefly explain 3 clinical outcomes of PE [3]

A
  1. Cardiac failure (see next slide)
  2. Respiratory failure: due to V/Q mistmatch (part of lung not perfused bc blocked by thrombus); low right ventricle output; patent foramen ovale
  3. Pulmonary infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain mechanism of how heparin works to treat PE [3]

Name a drug that is a synthetic heparin [1]

A

Heparin binds to antithrombin and activates it; activated complex then inactivates factor Xa, preventing conversion of prothrombin to thrombin (thrombin converts fibrinogen into fibrin - integral step in clot formation)

Fondaprinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why is heparin treatment potentially dangerous? [2]

A

Can cause bleeding in brain; retroperitoneal; site of fall [1]

Causes thrombocytopenia: platelet count drops, but increased risk of thrombus [1]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are specific treatments for pregnant; breast feeding and patients with cancer assosciated thrombosis? [3]

A

Specific treatments:

· During pregnancy:
o LMWHeparin throughout pregnancy - NOT warfarin or DOACs as they cross the placenta

During breast feeding
o LMWH and warfarin can be used.

Patient with cancer-associated thrombosis
o LMWH more effective than warfarin
o DOACs being evaluated.

23
Q

Which artery is occluded here? Explain what type of ACS is causing this ECG [1]

a) LAD
b) RCA
c) LCA
d) circumflex artery

A

Which artery is occluded here? Explain what type of ACS is causing this ECG [1]

a) LAD
b) RCA
c) LCA
d) circumflex artery: ST depression in V5 & V6

24
Q

What is the difference in the pathology of STEMI vs non STEMI?

A

Pathophysiology of acute MI:

· NSTEMI
o Ruptured coronary plaque with sub-occlusive thrombus - impacted flow of oxygen to myocytes & therefore myocyte necrosis
o Plaques rupture when they are unstable and there is friction from passing blood (statins can stabilise the plaque)
o Thrombus forms but occludes part of the lumen
o NON-diagnostic ECG

· STEMI
o Ruptured coronary plaque with occlusive thrombus - impacted flow of oxygen to myocytes & therefore myocyte necrosis
o Thrombus forms occluding the whole lumen
o DIAGNOSTIC ECG

25
Q

Diagnosis of MI need which criteria? [3]

A

ALL OF:

  1. Acute MI - troponin must be elevated
  2. Rise and/or fall of troponin with at least one value >99th percentile of the Upper Range of Normality (URL)

3. Clinical evidence of acute MI
- Symptoms of acute MI
- ECG changes (Q wave)
- ID of coronary thrombus by angiography
- Imaging from MRI / Echo

Anterior Q waves (V1-4) with ST elevation due to acute MI
26
Q

After patient examination, what would suggest an ACS? (risk factors)

(name two signs of high lipids) [2]

A

Could be no signs

Risk factors:
- hypertension
- smoking / tabacco stains
- high lipids: Xanthelasma (harmless, yellow growth that appears on or by the corners of your eyelids next to your nose), Arcus lipidus (white, light grey, or blueish ring around the edge of the cornea)

27
Q

What is the treatment if a STEMI is detected? [3]

A

Open the occluded artery as soon as possible to restore blood flow to the heart (Time is Muscle) (angioplasty) at heart attack centre. less than120 mins is aim

If can’t open artery via stent aim to thromboylse (but want to avoid because have high risk of bleeding).

Reperfusion therapy:
- Aspirin + ticagrelor or pragural (dual antiplatelets)
- Heparin
- PCI

28
Q

What is the treatment if a non- STEMI is detected? [5]

A

· Treatment:

o Aspirin + ticagrelor

o +/- GP IIb/IIIa inhibitor (prevent platelet aggregation by blocking glycoprotein IIb/IIIa receptors on their platelet’s)

o Fondaparinux - factor Xa inhibitor

o Anti-ischemic drugs - BB/nitrates

o Angiography, followed by +/- PCI within 24-96 hrs.

· Idea is to thin blood to fit through the semi-occluded gap - then use angiography within 24 hours of presentation to resolve the partial occlusion.

BATMAN

B – Beta-blockers unless contraindicated

A – Aspirin 300mg stat dose

T – Ticagrelor 180mg stat dose (clopidogrel 300mg is an alternative if higher bleeding risk)

M – Morphine titrated to control pain

A – Anticoagulant: Fondaparinux (unless high bleeding risk)

N – Nitrates (e.g. GTN) to relieve coronary artery spasm

Give oxygen only if their oxygen saturations are dropping (i.e. <95%).

29
Q

What does this ECG indicate? [2]

A

T wave depression in V1-V3
Occlusion in LAD

30
Q

If suspect ACS / MI when should you do an ECG?

A

First thing! If possible do history at same time
It is important that serial/repeat ECGs are performed if initial ECG- normal

31
Q

How do you chose which antiplatelet should use for unstable angina, NSTEMI [3] or STEMI? [2]

A

Acute STEMI: Prasugrel & Aspirin

Unstable angina and NSTEMI who are having coronary angiography: Prasugrel or ticagrelor, as part of DAPT with aspirin

32
Q

What are the two types of treatment for haemophilia? [2]

What type of medication can you give for haemophilia? [3]

A

Two types of treatment:
Prophylaxis
On-Demand

Medication:
Factor VIII/ IX- recombinant or plasma (IV)
Desmopresssin / DDAVP (S/C) - causes the release of von Willebrand’s antigen from the platelets and the cells that line the blood vessels where it is stored. Von Willebrand’s antigen is the protein that carries factor VIII.
Tranexamic Acid (IV and Oral) - Antifibrinolytic (stops fribrinlysis)

33
Q

What are the three different types of VWD?

A

Type 1– A reduction in von Willebrand antigen and factor FVIII as a result. Autosomal dom
(Quantitative)

Type 2– von Willebrand factor doesn’t work properly and therefore have a low RiCof . Autosomal dom
(Qualitative)

Type 3 – Extremely low levels or complete absence of Von Willebrand antigen, RiCof and factor VIII. Autosomal recessive.
(Quantitative). Most severe

34
Q

Symptoms of VWD? [6]

A

Frequent nose bleeds
Easy bruising
Gum bleeds (Teeth falling out & extractions)
Menorrhagia
Menstrual bleeding lasting more than 7 days
Intestinal/gut bleeding
Symptoms and their severity vary greatly

35
Q

What are the two types of treatment for VWD? [2]

What type of medication can you give for VWD? [3]

A

Two types:
Prophylaxis (Type 3 only)
On-Demand

Medication:
(Von Willebrand disease does not require day to day treatment. Management is required either in response to major bleeding or trauma (to stop bleeding) or in preparation for operations (to prevent bleeding):)

  • Wilate and Voncento: FVIII and vWF (IV)
  • DDAVP (S/C) Desmopressin (Inducing synthesis of the von Willebrand factor (VWF) by endothelial cells)
  • Tranexamic Acid (IV and Oral) - stops heavy bleeding
36
Q

Explain the basic overview from vessel injury –> stable haemostatitc plug

A
  1. Vasoconstriction occurs to reduce blood loss
  2. Collagen released is also. This causes platelet released, which in turn causes release of serotonin, TXA ADP & platelet phospholipids.
  3. Serotonin then helps with vasoconstriction, whilst TXAADP helps with platelet aggregation.
  4. Together they help to make a primary plug
  5. Through vasoconstriction, shear stress is increased. This cause various molecules to be release, including VWF (important in platelets adhering to vessel walls)
  6. Simultaneously to vasoconstriction: tissues factor is exposed. This causes coagulation cascade.
  7. Platelet Phospholipid is the surface for many of the coagulation cascade that occurs.
  8. Thrombin is created  fibrin
  9. together makes stable hameostatic plug
37
Q

Give brief overview on how primary haemostasis occurs to make platelet plug

A
  1. Vessel injury causes collagen to be exposed
  2. VWF binds to collagen one side, and the otherside to platelets via glycoprotein 1b receptor
  3. Platelets become activated, start clump other platelets. Through glycoprotein IIb, IIIa and fibrin, form stable haemostatic plug.
38
Q

Fill in the differences

A
39
Q

Role of von Willebrand factor? [2]

A

Large glycoprotein which forms massive multimers up to 1,000,000 Da in size
1. promotes platelet adhesion to damaged endothelium
2. carrier molecule for factor VIII

40
Q

Which chemoreceptors detect change in CO2?

A

Peripheral chemoreceptors in carotid bodies detect pO2 / hypoxiaemia

Central chemoreceptors in medulla detect pH & paCO2, not O2!

41
Q

Describe initial the physiological response to hypoxaemia occuring at high altitude

A

Low pO2 detected in peripheral chemoreceptors: causes hyperventilation.

Hyperventilation causes Co2 levels to decrease

This is detected by central chemoreceptors to try and stop hyperventilating.

Still hyperventilate, just less compared to level that would if had high Co2

A conflict of chemoreceptors !!

42
Q

Describe 3 physiological changes that initially occur (after 3 hours) at high altitude [4]

A
  1. Sympathtic NS activated: increase HR, CO, BP. (BP normalise with time)
  2. Ventilation / perfusion matching mechanism stimulated by low O2: causes pulmonary vasoconstriction: causes increased hypoxaemia (maladaption)
  3. Plasma volume decreases due to diuresis caused by carbonic anhydrase action: increases hematocrit
  4. More EPO produced at kidney: increased RBC count
43
Q

Describe how the kidney reabsorbs bicarbonate under normal physiological conditions

A

At PCT of Kidney, body reabsorbs most HCO3-.

  1. HCO3- filtered through glomerulus.
  2. Activity of carbonic anhydrase inside AND outside cell is increased.
  3. Increased intracellular CA activity increases excretion of H+ outside of the cell through the Na/H+ ATPase pump.
  4. Extracelluar H+ then reacts with HCO3-, via carbonic anhydrase, to make Co2 and H20
  5. Co2 reabsorbed into cell. CO2 reacts with H20 via CA to make more H+. repeat
  6. HCO3- absorbed into blood
44
Q

Describe how the kidney reabsorbs bicarbonate if there is respiratory alkalosis

A
  1. Decreased carbonic anhydrase activity within the cell: less CO2 converted to bicarbonate and protons. Less protons in cell means less protons excreted by sodium-proton exchange ATPase in luminal wall into urine to be excreted.
  2. This results in less bicarbonate is converted to CO2 in tubule and filtered bicarbonate is excreted in urine
  3. Leads to decreased excretion protons and decreased bicarbonate reabsorption
45
Q

How does pulmonary vascular resistance acclimatise to high altitude? [1]

How? [1]

A

During acclimatisation pulmonary vascular resistance due to vasoconstriction falls.

Due to release of nitrous oxide

46
Q

Name 4 physiological response that occur for acclimatisation to occur? [5]

A
  1. Pulmonary vascular resistance falling
  2. EPO raises - increase in Hb
  3. blood pH adjustment
  4. CSF pH normalised
  5. 2,3 DPG levels increase
47
Q

Name the 3 diseases that can occur if ascent is too rapid xx [3]

A

1. AMS: Acute Mountain Sickness. The first sign that something is wrong. Major determinants of AMS are the altitude attained, individual susceptibility, rate of ascent and degree of pre-acclimatisation

2. HACE: High Altitude Cerebral Edema Can follow on from AMS. A serious neurological condition; fatal if not treated.

3. HAPE: High Altitude Pulmonary Edema. Equally serious pulmonary condition which can follow on from AMS.

48
Q

How do you treat AMS? if mild? [1]
How do you treat AMS? if severe? [4]

A

A) If mild, rest (no further ascent !) for 24-48 hours
B) If more severe then:
Immediate Descent
Oxygen
Acetazolamide 250mg tds (three times daily) - carbonic anhydrase inhibitors
Dexamethasone 4mg qds, (four times daily) oral or iv (steroid): corticosteroid medication used to prevent brain swelling and inflammation.

49
Q

Describe the MoA of Acetazolamide xx [2]

A

Acetazolamide is a carbonic anhydrase (CA) inhibitor.

Acetazolamide speeds up reduction in carbonic anhydrase activity occurring naturally with acclimatization: reducing bicarbonate reabsorption and renal proton excretion

Acetazolamide inhibits carbonic anhydrase in erythrocytes - reduced transport of CO2 from tissues to lungs and thus decreases loss of CO2 in lungs counteracting excessive loss of CO2 from body by hyperventilation.

(better for prevention)

50
Q

Explain the MoA behind HACE

A

In hypoxaemia ATP supply in nerve cells decreases and sodium pumps run down
Sodium leaks into nerve cellpulling water with it brain cells swell.
Raises intracranial pressure (icp) and blocks cerebral veins
Cerebral circulation fails, hypoxia worsens, neurons, starved of oxygen and squashed together, start to die.
Dead neurons release ions and fluids – worsen cerebral oedema

51
Q

Treatment of HACE [4]

A

Recognition!
Descend immediately
Dexamethasone orally or intravenously (prevents brain swelling)
Acetazolamide (reduces intracranial pressure by reducing cerebrospinal fluid volume)
Oxygen
Hyperbaric oxygen treatment (portable chambers now available)

52
Q

Explain MoA of HAPE xx

A

Initial hypoxic pulmonary vasoconstriction normally decreases with acclimatization.

If this does not occur pulmonary arterial hypertension can develop.

Raised pulmonary capillary pressure leads to fluid leaving blood and entering the alveoli causing pulmonary oedema.

This worsens already compromised gas exchange which increases hypoxia and increases vasoconstriction and vicious circle occurs.

53
Q

Treatment of HAPE? [6]

A

Descend immediately
Sit patient upright
Oxygen
Acetazolamide
Dexamethason
Nifedipine: calcium channel blocker that relaxes vascular smooth muscle
Hyperbaric oxygen chamber
Sildenafil (Viagra): relaxes pulmonary vascular smooth muscle (it increases levels of cGMP & decreases intracellular calcium)

54
Q

Explain the mechansim of action of an ADP receptor antagonist [2]

Name three of the most common [3]

A

The ADP receptor antagonists bind to the P2Y12 receptor to prevent ADP-induced platelet activation

Clopidogrel
Prasugrel
Ticagrelor